About
Technology
Issues
FAQ
Links
Official Page
Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia: updated phase 2 results
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.
